Medindia

X

Boost for Gene Therapy Following European Endorsement

by Kathy Jones on  July 22, 2012 at 12:05 AM Genetics & Stem Cells News   - G J E 4
Gene therapy is on the verge of becoming a mainstream treatment option after European regulators recommended that the European Medicine Agency approve Glybera for treating lipoprotein lipase deficiency.
 Boost for Gene Therapy Following European Endorsement
Boost for Gene Therapy Following European Endorsement
Advertisement

Lipoprotein lipase deficiency is a rare genetic disorder in which the pancreas swells due to the non production of enzyme responsible for breaking down fat and affects just one in one million. Glybera, manufactured by uniQure of Amsterdam, had been initially rejected by the EMA last year but its Committee for Medicinal Products for Human Use revised the decision after it found that the treatment is effective in a small group of people who suffer from severe or multiple attacks of pancreatitis.

Advertisement
Speaking to The Guardian, former director of the US Food and Drug Administration's office of orphan products development, Tim Cote said that the approval of Glybera could prove to be a major milestone in gene therapy treatments.

"This is a watershed moment. Gene therapy holds incredible promise for people, especially those with rare diseases. This is not an isolated example, this is the beginning of something. It paves the way for the approval of other treatments of this kind", he said.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All